Senate Health Committee advances more than a dozen public‑health bills to first reading

The New York State Senate Health Committee on March 4, 2025 advanced more than a dozen public‑health bills, sending most to first reading or to other committees for further consideration.

The committee moved bills on managed long‑term care reporting, protections for school‑based health centers, informed‑consent rules for psychotropic drugs in nursing homes and adult‑care facilities, lowered blood‑lead thresholds, limits on pay‑for‑delay drug deals, and a measure to restore higher state reimbursement for certain New York City public‑health programs, among others.

Committee chair (unnamed) described the first measure, Senate Bill 707, as expanding and changing reporting requirements for managed long‑term care plans and converting reporting from biennial to annual, saying a report “would give us a lot more information to work from.” The chair also said, as recorded in the transcript, “Spoiler alert: we don't make them or want them.”

Senate Bill 893, from Senator Sapulveda, would narrow informed‑consent requirements for use of psychotropic medications in nursing homes and adult‑care facilities; the committee referred that bill to the Aging Committee. Senator Krueger’s bill to fund abortion services and travel costs for New York State residents who are active‑duty service members, their spouses or dependents was advanced to the Finance Committee after brief questions about how “resident” would be defined in other law.

A bill from Senator Fernandez would lower the blood‑lead level that states a public‑health threshold; committee discussion referenced a prior state standard of 5 micrograms per deciliter and the Centers for Disease Control and Prevention guideline at 3.5 micrograms per deciliter.

Senator Gruber, speaking on Senate Bill 1714, asked the panel to prohibit the use of the term “excited delirium” as a diagnosis, label or cause of death. Gruber said the term is “a non‑scientific term” and referenced statements by national medical organizations that have criticized the designation and its use in law‑enforcement custody cases.

Several bills targeted procedural or programmatic changes: SB1224 would change transparency and review processes for Medicaid coverage of new technologies; SB3184 would allow certain adult‑care facilities to arrange limited short‑term nursing services; SB3361 would expand who can perform medical evaluations for assisted‑living eligibility; SB2400 would establish a Blood Clot and Pulmonary Embolism Policy Work Group; and SB3203 would address bans on so‑called pay‑for‑delay settlements by drug manufacturers.

A bill from the chair, SB4801, would restore the state reimbursement rate for certain Article 6 public‑health programs provided by New York City from the reduced level set in 2019 back to the prior 36 percent rate; the chair said the earlier change cut roughly $62,000,000 in city public‑health funding. Committee members clarified that those Article 6 programs are separate from Medicaid and include family health, communicable disease control, chronic disease prevention, environmental health and public‑health emergency preparedness.

Most measures were moved, seconded and approved in voice votes with no extended debate. A small number of bills recorded objections or “nay” votes that were noted on the transcript; when present, the transcript named dissenting members by voice. Each bill advanced carries standard legislative steps: referral to first reading or to a committee such as Aging or Finance for further action.

The committee concluded its agenda after advancing the listed measures; several sponsors and members said they would pursue further action as bills proceed through the legislative process.